カテゴリ： Stratistics MRC, 世界, 医療/バイオ

キナーゼ阻害剤の世界市場2019-2027

◆英語タイトル：Kinase Inhibitors - Global Market Outlook (2019-2027)
◆商品コード：SMRC20JL256
◆発行会社（リサーチ会社）：Stratistics MRC
◆発行日：2020年6月30日
◆ページ数：160
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆調査対象地域：グローバル
◆販売価格オプション（消費税別）
Single UserUSD4,150 ⇒換算￥435,750見積依頼/購入/質問フォーム
Five UserUSD5,250 ⇒換算￥551,250見積依頼/購入/質問フォーム
Global Site LicenseUSD7,500 ⇒換算￥787,500見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はStratistics MRC社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
※Stratistics MRC社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。
本調査レポートでは、キナーゼ阻害剤の世界市場を広く調査・分析し、エグゼクティブサマリー、序論、市場動向分析、ファイブフォース分析、種類別（受容体型チロシンキナーゼ阻害剤、非受容体型チロシンキナーゼ阻害剤、血管新生阻害剤、プロテインキナーゼC阻害剤、その他）分析、流通チャンネル別分析、用途別分析、エンドユーザー別分析、地域別分析、主要な市場開拓、企業情報など、今後の市場展望をまとめております。
・エグゼクティブサマリー
・序論
・市場動向分析
・ファイブフォース分析
・キナーゼ阻害剤の世界市場規模：種類別（受容体型チロシンキナーゼ阻害剤、非受容体型チロシンキナーゼ阻害剤、血管新生阻害剤、プロテインキナーゼC阻害剤、その他）
・キナーゼ阻害剤の世界市場規模：流通チャンネル別
・キナーゼ阻害剤の世界市場規模：用途別
・キナーゼ阻害剤の世界市場規模：エンドユーザー別
・キナーゼ阻害剤の世界市場規模：地域別
・主要な市場開拓
・企業情報
【レポートの概要】

Accord ing to Stratistics MRC, the Global Kinase Inhibitors Market is accounted for $40.41 billion in 2019 and is expected to reach $64.90 billion by 2027 growing at a CAGR of 6.1% during the forecast period. Some of the key factors propelling the market growth include rise in awareness about kinase inhibitors, surge in product approvals, increase in incident of cancer diseases, and increase in investment from pharmaceutical companies. However, cost of treatment and lack of funds in conducting research are likely to restraint the market. In addition, increase in adoption of kinase inhibitors for newer applications, and emerging economies such as China, India and others, will create new opportunities for global kinase inhibitors market.

Kinase inhibitors are considered as specific enzymes that help in preventing the process of cell division and the growth of cancerous cells. These inhibitors are easy to use and are handy while treating cancer patients by blocking the signals that alert the cancer cells to grow. With the help of research and development activities in the cancer treatments, several innovations, and advanced therapeutics have been introduced. However, the results of these drugs and treatments are considered partial, palliative, and unpredictable at times. Kinase inhibitors are being highly publicized as a potential treatment for alopecia areata (AA).

By application, the oncology segment is expected to grow at the significant rate during the forecast period. Large number of approved drugs along with rich product pipeline for cancer treatment is anticipated to fuel the growth of the segment in the near future. Based on data from clinicaltrials.gov last updated on January 2020, over 75 kinase inhibitor drugs are in various phases of clinical trials for the application of oncology. On the basis of geography, North America is anticipated to have considerable market growth during the forecast period, due to rise in awareness about new drugs for treatment, availability of all major companies in the region, the introduction of new drugs, and high prevalence of cases in U.S.

Some of the key players in kinase inhibitors market include Меrсk Ѕеrоnо Ѕа, Nоvаrtіѕ Іntеrnаtіоnаl Аg, Incyte Corporation, Glaxo SmithKline, Суtrх Соrроrаtіоn, Оѕі Рhаrmасеutісаlѕ Llс, AstraZeneca, Eisai Co., Ltd., Bristol-Myers Squibb, Bayer AG, Pfizer Inc., Takeda Pharmaceutical Company Limited, Boehringer Ingelheim GmbH, Eisai Co., Ltd., Johnson & Johnson, Еtоn Віоѕсіеnсе Іnс., and F. Hoffmann-La Roche Ltd.

Types Covered:
• Receptor Tyrosine Kinase Inhibitors
• Non-receptor Tyrosine Kinase Inhibitors
• Angiogenesis Inhibitors
• Protein Kinase C Inhibitors
• RHO Kinase Inhibitors
• Multikinase inhibitors
• Serine/Threonine Kinase Inhibitors
• Tyrosin kinase inhibitors (TKI)
• Threonine kinase inhibitor
• mTOR Kinase Inhibitors
• BRAF Inhibitors
• Cyclin Dependant Kinase Inhibitor
• Aurora Kinase Inhibitors
• MAP/MEK Kinase Inhibitors
• Humanized Monoclonal Antibody
• Chimeric Monoclonal Antibody
• JNK Inhibitors
• PI3K Inhibitors
• Other Types

Distribution Channels Covered:
• Independent Pharmacies
• Hospital Pharmacies
• Online Pharmacies

Applications Covered:
• Inflammatory Diseases
• Oncology

End Users Covered:
• Scientific Research Labs
• Hospitals
• Academic Institutes
• Healthcare Facilities
• Pharmaceutical Companies
• Private and Government Research Institutes

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2018, 2019, 2020, 2024 and 2027
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter’s five forces analysis, SWOT analysis, etc.
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client’s interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

【レポートの目次】

1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 End User Analysis
3.8 Emerging Markets
3.9 Impact of Covid-19

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Kinase Inhibitors Market, By Type
5.1 Introduction
5.2 Receptor Tyrosine Kinase Inhibitors
5.2.1 Platelet-derived Growth Factor Receptors (PDGFR)
5.2.2 Vascular Endothelial Growth Factor Receptor (VEGFR)
5.2.3 Anaplastic lymphoma kinase (ALK)
5.2.4 Human Epidermal Growth Factor Receptor 2 (HER2)
5.2.5 Estimated Glomerular Filtration Rate (EGFR)
5.3 Non-receptor Tyrosine Kinase Inhibitors
5.3.1 Mesenchymal Epithelial Transition Growth Factor (c-MET)
5.3.2 Spleen Tyrosine Kinase (SYK) Inhibitors
5.3.3 Bruton’s Tyrosine Kinase (BTK) Inhibitors
5.3.4 BCR-ABL
5.3.5 Janus Kinase (JAK) Inhibitor
5.4 Angiogenesis Inhibitors
5.5 Protein Kinase C Inhibitors
5.6 RHO Kinase Inhibitors
5.7 Multikinase inhibitors
5.8 Serine/Threonine Kinase Inhibitors
5.9 Tyrosin kinase inhibitors (TKI)
5.10 Threonine kinase inhibitor
5.11 mTOR Kinase Inhibitors
5.12 BRAF Inhibitors
5.13 Cyclin Dependant Kinase Inhibitor
5.14 Aurora Kinase Inhibitors
5.15 MAP/MEK Kinase Inhibitors
5.16 Humanized Monoclonal Antibody
5.17 Chimeric Monoclonal Antibody
5.18 JNK Inhibitors
5.19 PI3K Inhibitors
5.20 Other Types
5.20.1 Monoclonal Antibody Kinase Inhibitor

6 Global Kinase Inhibitors Market, By Distribution Channel
6.1 Introduction
6.2 Independent Pharmacies
6.3 Hospital Pharmacies
6.4 Online Pharmacies

7 Global Kinase Inhibitors Market, By Application
7.1 Introduction
7.2 Inflammatory Diseases
7.3 Oncology
7.3.1 Lung Cancer
7.3.2 Renal Cell Cancer
7.3.3 Breast Cancer

8 Global Kinase Inhibitors Market, By End User
8.1 Introduction
8.2 Scientific Research Labs
8.3 Hospitals
8.4 Academic Institutes
8.5 Healthcare Facilities
8.6 Pharmaceutical Companies
8.7 Private and Government Research Institutes

9 Global Kinase Inhibitors Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa

10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies

11 Company Profiling
11.1 Меrсk Ѕеrоnо Ѕа
11.2 Nоvаrtіѕ Іntеrnаtіоnаl Аg
11.3 Incyte Corporation
11.4 Glaxo SmithKline
11.5 Суtrх Соrроrаtіоn
11.6 Оѕі Рhаrmасеutісаlѕ Llс
11.7 AstraZeneca, Eisai Co., Ltd.
11.8 Bristol-Myers Squibb
11.9 Bayer AG
11.10 Pfizer Inc.
11.11 Takeda Pharmaceutical Company Limited
11.12 Boehringer Ingelheim GmbH
11.13 Eisai Co., Ltd.
11.14 Johnson & Johnson
11.15 Еtоn Віоѕсіеnсе Іnс.
11.16 F. Hoffmann-La Roche Ltd

List of Tables
Table 1 Global Kinase Inhibitors Market Outlook, By Region (2018-2027) ($MN)
Table 2 Global Kinase Inhibitors Market Outlook, By Type (2018-2027) ($MN)
Table 3 Global Kinase Inhibitors Market Outlook, By Receptor Tyrosine Kinase Inhibitors (2018-2027) ($MN)
Table 4 Global Kinase Inhibitors Market Outlook, By Platelet-derived Growth Factor Receptors (PDGFR) (2018-2027) ($MN)
Table 5 Global Kinase Inhibitors Market Outlook, By Vascular Endothelial Growth Factor Receptor (VEGFR) (2018-2027) ($MN)
Table 6 Global Kinase Inhibitors Market Outlook, By Anaplastic lymphoma kinase (ALK) (2018-2027) ($MN)
Table 7 Global Kinase Inhibitors Market Outlook, By Human Epidermal Growth Factor Receptor 2 (HER2) (2018-2027) ($MN)
Table 8 Global Kinase Inhibitors Market Outlook, By Estimated Glomerular Filtration Rate (EGFR) (2018-2027) ($MN)
Table 9 Global Kinase Inhibitors Market Outlook, By Non-receptor Tyrosine Kinase Inhibitors (2018-2027) ($MN)
Table 10 Global Kinase Inhibitors Market Outlook, By Mesenchymal Epithelial Transition Growth Factor (c-MET) (2018-2027) ($MN)
Table 11 Global Kinase Inhibitors Market Outlook, By Spleen Tyrosine Kinase (SYK) Inhibitors (2018-2027) ($MN)
Table 12 Global Kinase Inhibitors Market Outlook, By Bruton’s Tyrosine Kinase (BTK) Inhibitors (2018-2027) ($MN)
Table 13 Global Kinase Inhibitors Market Outlook, By BCR-ABL (2018-2027) ($MN)
Table 14 Global Kinase Inhibitors Market Outlook, By Janus Kinase (JAK) Inhibitor (2018-2027) ($MN)
Table 15 Global Kinase Inhibitors Market Outlook, By Angiogenesis Inhibitors (2018-2027) ($MN)
Table 16 Global Kinase Inhibitors Market Outlook, By Protein Kinase C Inhibitors (2018-2027) ($MN)
Table 17 Global Kinase Inhibitors Market Outlook, By RHO Kinase Inhibitors (2018-2027) ($MN)
Table 18 Global Kinase Inhibitors Market Outlook, By Multikinase inhibitors (2018-2027) ($MN)
Table 19 Global Kinase Inhibitors Market Outlook, By Serine/Threonine Kinase Inhibitors (2018-2027) ($MN)
Table 20 Global Kinase Inhibitors Market Outlook, By Tyrosin kinase inhibitors (TKI) (2018-2027) ($MN)
Table 21 Global Kinase Inhibitors Market Outlook, By Threonine kinase inhibitor (2018-2027) ($MN)
Table 22 Global Kinase Inhibitors Market Outlook, By mTOR Kinase Inhibitors (2018-2027) ($MN)
Table 23 Global Kinase Inhibitors Market Outlook, By BRAF Inhibitors (2018-2027) ($MN)
Table 24 Global Kinase Inhibitors Market Outlook, By Cyclin Dependant Kinase Inhibitor (2018-2027) ($MN)
Table 25 Global Kinase Inhibitors Market Outlook, By Aurora Kinase Inhibitors (2018-2027) ($MN)
Table 26 Global Kinase Inhibitors Market Outlook, By MAP/MEK Kinase Inhibitors (2018-2027) ($MN)
Table 27 Global Kinase Inhibitors Market Outlook, By Humanized Monoclonal Antibody (2018-2027) ($MN)
Table 28 Global Kinase Inhibitors Market Outlook, By Chimeric Monoclonal Antibody (2018-2027) ($MN)
Table 29 Global Kinase Inhibitors Market Outlook, By JNK Inhibitors (2018-2027) ($MN)
Table 30 Global Kinase Inhibitors Market Outlook, By PI3K Inhibitors (2018-2027) ($MN)
Table 31 Global Kinase Inhibitors Market Outlook, By Other Types (2018-2027) ($MN)
Table 32 Global Kinase Inhibitors Market Outlook, By Monoclonal Antibody Kinase Inhibitor (2018-2027) ($MN)
Table 33 Global Kinase Inhibitors Market Outlook, By Distribution Channel (2018-2027) ($MN)
Table 34 Global Kinase Inhibitors Market Outlook, By Independent Pharmacies (2018-2027) ($MN)
Table 35 Global Kinase Inhibitors Market Outlook, By Hospital Pharmacies (2018-2027) ($MN)
Table 36 Global Kinase Inhibitors Market Outlook, By Online Pharmacies (2018-2027) ($MN)
Table 37 Global Kinase Inhibitors Market Outlook, By Application (2018-2027) ($MN)
Table 38 Global Kinase Inhibitors Market Outlook, By Inflammatory Diseases (2018-2027) ($MN)
Table 39 Global Kinase Inhibitors Market Outlook, By Oncology (2018-2027) ($MN)
Table 40 Global Kinase Inhibitors Market Outlook, By Lung Cancer (2018-2027) ($MN)
Table 41 Global Kinase Inhibitors Market Outlook, By Renal Cell Cancer (2018-2027) ($MN)
Table 42 Global Kinase Inhibitors Market Outlook, By Breast Cancer (2018-2027) ($MN)
Table 43 Global Kinase Inhibitors Market Outlook, By End User (2018-2027) ($MN)
Table 44 Global Kinase Inhibitors Market Outlook, By Scientific Research Labs (2018-2027) ($MN)
Table 45 Global Kinase Inhibitors Market Outlook, By Hospitals (2018-2027) ($MN)
Table 46 Global Kinase Inhibitors Market Outlook, By Academic Institutes (2018-2027) ($MN)
Table 47 Global Kinase Inhibitors Market Outlook, By Healthcare Facilities (2018-2027) ($MN)
Table 48 Global Kinase Inhibitors Market Outlook, By Pharmaceutical Companies (2018-2027) ($MN)
Table 49 Global Kinase Inhibitors Market Outlook, By Private and Government Research Institutes (2018-2027) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.



【免責事項】
https://www.marketreport.jp/reports-disclaimer
★医療情報レポート[キナーゼ阻害剤の世界市場2019-2027]についてメールでお問い合わせはこちら

※関連の医療情報レポート

  1. 泌尿器科用画像機器の世界市場2019-2027
    SMRC20JL480 / Stratistics MRC / 2020年6月30日 / 本調査レポートでは、泌尿器科用画像機器の世界市場を広く調査・分析し、エグゼクティブサマリー、序論、市場動向分析、ファイブフォース分析、種類別（受容体型チロシンキナーゼ阻害剤、非受容体型チロシンキナーゼ阻害剤、セリン/スレオニンキナーゼ阻害剤、RHOキナーゼ阻害剤、マルチキナーゼ阻害剤）分析、流通チャネル別分析、用途別分析、エンドユーザー別分析、地域別分析、主要な市場開拓、企業情報など、今後の市場展望をまとめております。 ・エグゼクティブサマリー ・序論 ・市場動向分析 ・ファイブフォース分析 ・泌尿器科用画像機器の世界市場規模：種類別（受容体型チロシンキナーゼ阻害剤、非受容体型チロシンキナーゼ阻害剤、セリン/スレオニンキナーゼ阻害剤、RHOキナーゼ阻害剤、マルチキナーゼ阻害剤） ・泌尿器科用画像機器の世界市場規模：流通チャネル別 ・泌尿器科用画像機器の世界市場規模：用途別 ・泌尿器科用画像機器の世界市場規模：エンドユーザー別 ・泌尿器科用画像機器の世界市場規模：地域別...According to Stratistics MRC, the Global Urology Imaging Equipment market is accounted for $1.38 billion in 2019 and is expected to reach $2.18 billion by 2027 growing at a CAGR of 5.9% during the forecast period. Some of the key factors propelling the market growth include increasing binge eating and consumption of junk foods, neglect towards regular exercise, rising levels of stress, adoption of multimodality imaging technologies, and rise in prevalence of urology diseases. However, product recall and high cost are likely to restraint the market. By type, the x-ray/fluoroscopy imaging systems segment is projected to grow at the significant...
  2. 組換えC因子(rFC)アッセイの世界市場2019-2027
    SMRC20JL384 / Stratistics MRC / 2020年6月30日 / 本調査レポートでは、組換えC因子(rFC)アッセイの世界市場を広く調査・分析し、エグゼクティブサマリー、序論、市場動向分析、ファイブフォース分析、エンドユーザー別（受託研究機関（CRO）、バイオテクノロジー企業、医療機器会社、製薬会社）分析、ブランド別分析、地域別分析、主要な市場開拓、企業情報など、今後の市場展望をまとめております。 ・エグゼクティブサマリー ・序論 ・市場動向分析 ・ファイブフォース分析 ・組換えC因子(rFC)アッセイの世界市場規模：エンドユーザー別（受託研究機関（CRO）、バイオテクノロジー企業、医療機器会社、製薬会社） ・組換えC因子(rFC)アッセイの世界市場規模：ブランド別 ・組換えC因子(rFC)アッセイの世界市場規模：地域別 ・主要な市場開拓 ・企業情報...According to Stratistics MRC, the Global Recombinant Factor C Assay Market is accounted for $14.29 million in 2019 and is expected to reach $30.40 million by 2027 growing at a CAGR of 9.9% during the forecast period. The rise in need of alternative endotoxin detection tests and cost advantages by helping in reducing the operator risks is propelling the market growth. However, the lack of long-term studies that validate rFC for combination testing of unknown samples is hampering the market growth. Recombinant factor C (rFC) assay is an alternative to LAL tests utilized for endotoxin testing of the products for...
  3. 腫瘍栄養の世界市場2019-2027
    SMRC20JL333 / Stratistics MRC / 2020年6月30日 / 本調査レポートでは、腫瘍栄養の世界市場を広く調査・分析し、エグゼクティブサマリー、序論、市場動向分析、ファイブフォース分析、がん種類別（乳がん、血液がん、頭頸部がん、胃がん・消化器がん、食道がん）分析、処方別分析、栄養別分析、流通チャネル別分析、ステージ別分析、製品別分析、エンドユーザー別分析、地域別分析、主要な市場開拓、企業情報など、今後の市場展望をまとめております。 ・エグゼクティブサマリー ・序論 ・市場動向分析 ・ファイブフォース分析 ・腫瘍栄養の世界市場規模：がん種類別（乳がん、血液がん、頭頸部がん、胃がん・消化器がん、食道がん） ・腫瘍栄養の世界市場規模：処方別 ・腫瘍栄養の世界市場規模：栄養別 ・腫瘍栄養の世界市場規模：流通チャネル別 ・腫瘍栄養の世界市場規模：ステージ別...According to Stratistics MRC, the Global Oncology Nutrition market is accounted for $1.64 billion in 2019 and is expected to reach $3.64 billion by 2027 growing at a CAGR of 10.5% during the forecast period. Some of the key factors propelling the market growth include shifting focus from parenteral to enteral nutrition, growing demand for nutritional feeding in the homecare sector, increasing incidence of cancer, rising number of patients being treated for malnutrition, and increasing quality of clinical research on nutritional interventions. However, tube feeding-related complications and restricted reimbursement associated with its use are the major restraints that can hamper...
  4. 心嚢穿刺処置の世界市場2019-2027
    SMRC20JL353 / Stratistics MRC / 2020年6月30日 / 本調査レポートでは、心嚢穿刺処置の世界市場を広く調査・分析し、エグゼクティブサマリー、序論、市場動向分析、ファイブフォース分析、疾患別（心臓病、感染症、炎症性/リウマチ、悪性腫瘍）分析、エンドユーザー別分析、地域別分析、主要な市場開拓、企業情報など、今後の市場展望をまとめております。 ・エグゼクティブサマリー ・序論 ・市場動向分析 ・ファイブフォース分析 ・心嚢穿刺処置の世界市場規模：疾患別（心臓病、感染症、炎症性/リウマチ、悪性腫瘍） ・心嚢穿刺処置の世界市場規模：エンドユーザー別 ・心嚢穿刺処置の世界市場規模：地域別 ・主要な市場開拓 ・企業情報...According to Stratistics MRC, the Global Pericardiocentesis Procedures Market is accounted for $144.30 million in 2019 and is expected to reach $230.00 million by 2027 growing at a CAGR of 6.0% during the forecast period. Increase in the geriatric population and high adoption of minimally invasive surgeries for treatment of different medical conditions are the major factors propelling the market growth. However, complications and risk associated with the surgery are hampering the market growth. Pericardiocentesis is a minimally invasive surgical procedure performed to remove the excess levels of fluid accumulated in the pericardium sac around the heart. The procedure involves...
  5. 超音波ジェルの世界市場2019-2027
    SMRC20JL474 / Stratistics MRC / 2020年6月30日 / 本調査レポートでは、超音波ジェルの世界市場を広く調査・分析し、エグゼクティブサマリー、序論、市場動向分析、ファイブフォース分析、エンドユーザー別（病院、外来手術センター、クリニック、診断センター）分析、種類別分析、地域別分析、主要な市場開拓、企業情報など、今後の市場展望をまとめております。 ・エグゼクティブサマリー ・序論 ・市場動向分析 ・ファイブフォース分析 ・超音波ジェルの世界市場規模：エンドユーザー別（病院、外来手術センター、クリニック、診断センター） ・超音波ジェルの世界市場規模：種類別 ・超音波ジェルの世界市場規模：地域別 ・主要な市場開拓 ・企業情報...According to Stratistics MRC, the Global Ultrasound Gels Market is accounted for $517.28 million in 2019 and is expected to reach $1,158.15 million by 2027 growing at a CAGR of 10.6% during the forecast period. Some of the key factors propelling the market growth are increasing demand from hospitals, low cost of the product, and rising awareness regarding breast cancer. However, the cooling effect of ultrasound gels is the restraining factor for the growth of the market. Ultrasound gels are the conductive medium which is generally composed of propylene glycol, water and sometimes a dye. It acts as a coupling...
  6. GAS咽頭炎診断の世界市場2019-2027
    SMRC20JL196 / Stratistics MRC / 2020年6月30日 / 本調査レポートでは、GAS咽頭炎診断の世界市場について調査・分析し、エグゼクティブサマリー、序論、市場動向分析、ファイブフォース分析、製品別（PCRベーステスト、迅速試験キット、培養検査）、エンドユーザー別分析、地域別分析、主要な市場開拓、企業情報などを含めており、以下の構成で提供いたします。 ・エグゼクティブサマリー ・序論 ・市場動向分析 ・ファイブフォース分析 ・GAS咽頭炎診断の世界市場規模：製品別（PCRベーステスト、迅速試験キット、培養検査） ・GAS咽頭炎診断の世界市場規模：エンドユーザー別 ・GAS咽頭炎診断の世界市場規模：地域別 ・主要な市場開拓 ・企業情報...According to Stratistics MRC, the Global GAS Pharyngitis Diagnostics Market is accounted for $169.88 million in 2019 and is expected to reach $232.50 million by 2027 growing at a CAGR of 4.0% during the forecast period. Incidence and prevalence of gas pharyngitis infections are gradually growing across the globe and thereby driving the growth of the market. However, issues in providing accurate, efficient, and accessible diagnostics are restraining the growth of the market. Pharyngitis is inflammation of the pharynx, which is in the backside of the throat. It is most frequently referred to simply as sore throat. Numerous viral and...
  7. 創傷閉鎖ストリップの世界市場2019-2027
    SMRC20JL508 / Stratistics MRC / 2020年6月30日 / 本調査レポートでは、創傷閉鎖ストリップの世界市場を広く調査・分析し、エグゼクティブサマリー、序論、市場動向分析、ファイブフォース分析、種類別（強化、フレキシブル）分析、無菌性別分析、用途別分析、地域別分析、主要な市場開拓、企業情報など、今後の市場展望をまとめております。 ・エグゼクティブサマリー ・序論 ・市場動向分析 ・ファイブフォース分析 ・創傷閉鎖ストリップの世界市場規模：種類別（強化、フレキシブル） ・創傷閉鎖ストリップの世界市場規模：無菌性別 ・創傷閉鎖ストリップの世界市場規模：用途別 ・創傷閉鎖ストリップの世界市場規模：地域別 ・主要な市場開拓...According to Stratistics MRC, the Global Wound Closure Strips Market is accounted for $266.63 million in 2019 and is expected to reach $531.27 million by 2027 growing at a CAGR of 9.0% during the forecast period. Rising public and private healthcare expenditure and high demand for superior medical technologies are propelling the growth of the market. However, lack of awareness and shortage of resources is hampering the market growth. Wound closure strips are porous surgical tape strips which can be utilized to lock small injuries. They are applied over the cuts in a way which pulls the skin on either...
  8. 骨成長刺激剤の世界市場2019-2027
    SMRC20JL082 / Stratistics MRC / 2020年6月30日 / 本調査レポートでは、骨成長刺激剤の世界市場について調査・分析し、エグゼクティブサマリー、序論、市場動向分析、ファイブフォース分析、使用別（移植型骨成長刺激剤、外部骨成長刺激剤）分析、製品別分析、用途別分析、エンドユーザー別分析、地域別分析、主要な市場開拓、企業情報などを含めており、以下の構成で提供いたします。 ・エグゼクティブサマリー ・序論 ・市場動向分析 ・ファイブフォース分析 ・骨成長刺激剤の世界市場規模：使用別（移植型骨成長刺激剤、外部骨成長刺激剤） ・骨成長刺激剤の世界市場規模：製品別 ・骨成長刺激剤の世界市場規模：用途別 ・骨成長刺激剤の世界市場規模：エンドユーザー別 ・骨成長刺激剤の世界市場規模：地域別...According to Stratistics MRC, the Global Bone Growth Stimulators Market is accounted for $1.17 billion in 2019 and is expected to reach $2.07 billion by 2027 growing at a CAGR of 7.4% during the forecast period. Increasing investment in research and development and high electrical and magnetic field concept is propelling the market growth. However, high costs of installation and maintenance of the equipment are hampering the market growth. A bone expansion stimulator is a supplemental device worn to make new bone increase after spine surgeries such as cervical (neck) or lumbar (low back) spine surgery. In some cases, bone...
  9. HIVセルフテストキットの世界市場2019-2027
    SMRC20JL220 / Stratistics MRC / 2020年6月30日 / 本調査レポートでは、HIVセルフテストキットの世界市場について調査・分析し、エグゼクティブサマリー、序論、市場動向分析、ファイブフォース分析、テスト発生別（第3世代、第2世代）分析、標本種類別分析、製品別分析、エンドユーザー別分析、地域別分析、主要な市場開拓、企業情報などを含めており、以下の構成で提供いたします。 ・エグゼクティブサマリー ・序論 ・市場動向分析 ・ファイブフォース分析 ・HIVセルフテストキットの世界市場規模：テスト発生別（第3世代、第2世代） ・HIVセルフテストキットの世界市場規模：標本種類別 ・HIVセルフテストキットの世界市場規模：製品別 ・HIVセルフテストキットの世界市場規模：エンドユーザー別 ・HIVセルフテストキットの世界市場規模：地域別...According to Stratistics MRC, the Global HIV Self-test Kits Market is accounted for $71.76 million in 2019 and is expected to reach $288.56 million by 2027 growing at a CAGR of 19.0% during the forecast period. Rise in prevalence of this disease across the globe and growing uptake of HIV self-testing policies and implementation are the major factors driving the market growth. However, a false-negative result of these kits is restraining the market growth. HIV Self-test Kits helps the individuals to access critically important health information, at their convenience by conducting their own HIV test using a simple oral or...
  10. 高周波アブレーション装置の世界市場2019-2027
    SMRC20JL381 / Stratistics MRC / 2020年6月30日 / 本調査レポートでは、高周波アブレーション装置の世界市場を広く調査・分析し、エグゼクティブサマリー、序論、市場動向分析、ファイブフォース分析、種類別（双極高周波アブレーション、単極高周波アブレーション）分析、製品別分析、用途別分析、エンドユーザー別分析、地域別分析、主要な市場開拓、企業情報など、今後の市場展望をまとめております。 ・エグゼクティブサマリー ・序論 ・市場動向分析 ・ファイブフォース分析 ・高周波アブレーション装置の世界市場規模：種類別（双極高周波アブレーション、単極高周波アブレーション） ・高周波アブレーション装置の世界市場規模：製品別 ・高周波アブレーション装置の世界市場規模：用途別 ・高周波アブレーション装置の世界市場規模：エンドユーザー別 ・高周波アブレーション装置の世界市場規模：地域別...According to Stratistics MRC, the Global Radiofrequency Ablation Devices Market is accounted for $3.12 billion in 2019 and is expected to reach $8.67 billion by 2027 growing at a CAGR of 13.6% during the forecast period. Some of the key factors propelling the market growth are increasing geriatric population, rising occurrence of chronic disorders, and improving healthcare infrastructure. However, the high cost is the restraining factor for the growth of the market. Radiofrequency ablation is a minimally invasive procedure, suitable for patients with cardiac diseases, cancer and pain management. It is being increasingly preferred because of its high efficacy, ease...

◆H&Iグローバルリサーチ株式会社のお客様（例）◆